Clinical Trials Directory

Trials / Completed

CompletedNCT06440252

Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults

The Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults: a Randomised, Double-blind, Placebo-controlled Crossover Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
35 (actual)
Sponsor
RDC Clinical Pty Ltd · Industry
Sex
All
Age
25 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, double-blind, placebo-controlled, 2 arm crossover study conducted over 11 weeks, with participants randomised to a product for 4 weeks, followed by a 3-week washout period before completing the second product for 4 weeks, to study the effectiveness of a grape seed extract on circulatory measures in healthy adults.

Conditions

Interventions

TypeNameDescription
DRUGGrape Seed ExtractOne daily dose of 1 capsule containing 600mg grape seed extract
DRUGMaltodextrinOne daily dose of 1 capsule

Timeline

Start date
2024-10-31
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2024-06-03
Last updated
2026-03-06

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT06440252. Inclusion in this directory is not an endorsement.

Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults (NCT06440252) · Clinical Trials Directory